Home Featured

Featured

Reata Pharmaceuticals Inc (NASDAQ:RETA) Puts Out Positive PAH Data – What’s Next?

ME Contributor - June 24, 2016

Bayer AG (ADR) (OTCMKTS:BAYRY) is Pitching for a Big Win in Heart Failure

What’s The Market Potential Of Takeda’s Latest Approval?

Market Morning: IMO 2020 Confusion, Tesla Milestone, EV Skateboards, Boeing CEO Axed

Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

Atara’s Discontinuation Paints it as a Potential Short

ME Contributor - December 15, 2015

Cannabis Stock News Daily Roundup March 5

ME Staff - March 5, 2019

Is It Worth Following Celgene Corporation (NASDAQ:CELG) Into Jounce At IPO?

ME Contributor - January 3, 2017

Here’s What Just Happened With Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

ME Contributor - October 3, 2017

5 Reasons Why The Fed Won’t Hike Interest Rates Today

Rafi Farber - September 21, 2016

Market Morning Roundup: Kim Wants Trump, Russia Blamed For Shooting Down...

ME Staff - May 25, 2018

Acacia Needs a Suitor; Who Fits the Bill?

ME Contributor - January 21, 2016

The Week Ahead: Eurozone Crisis Moves to Spain, China Threatens, Russia...

ME Staff - June 4, 2018

Here’s What’s Moving Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) and IntelliPharmaCeutics Intl Inc...

ME Contributor - July 28, 2017

Cannabis Stock News Daily Roundup May 3

ME Staff - May 3, 2019

12 3...134 Page 1 of 134

/* */

EDITOR PICKS

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots,...

June 1, 2020

Market Morning: Moderna Miracle? Autos Fly On Lockdown Easing, NY Governor...

May 18, 2020

Market Morning: London Legalizes Moving, Congress and Fed Want More Spending,...

May 13, 2020

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.